TipRanks
Advertisement
Advertisement

MX:AZN1N Stock Latest News

NIH makes big bet on public-private partnership over cancer vaccines, NYT says
The FlyNIH makes big bet on public-private partnership over cancer vaccines, NYT says
2h ago
AZN
JNJ
Guardant announces Europe approval of Guardnat360 CDx as Etcamaha companion
PremiumThe Fly
Guardant announces Europe approval of Guardnat360 CDx as Etcamaha companion
23h ago
GH
AZN
Myriad, Sophia advance prostate cancer-specific genomic instability score tech
PremiumThe Fly
Myriad, Sophia advance prostate cancer-specific genomic instability score tech
1d ago
AZN
MYGN
Sophia Genetics and Myriad Genetics collaborate in prostate cancer score tech
PremiumThe Fly
Sophia Genetics and Myriad Genetics collaborate in prostate cancer score tech
1d ago
AZN
MYGN
AstraZeneca price target raised to 18,600 GBp from 17,800 GBp at Citi
PremiumThe Fly
AstraZeneca price target raised to 18,600 GBp from 17,800 GBp at Citi
3d ago
AZN
AstraZeneca opens R&D center in Cambridge, Massachusetts
PremiumThe FlyAstraZeneca opens R&D center in Cambridge, Massachusetts
4d ago
AZN
AstraZeneca: Strong Pipeline and Growth Outlook Support Buy Rating and Unchanged 16,500 GBp Price Target
Premium
Ratings
AstraZeneca: Strong Pipeline and Growth Outlook Support Buy Rating and Unchanged 16,500 GBp Price Target
4d ago
AZN
AstraZeneca completes $2B equity investment in Summit Therapeutics
Premium
The Fly
AstraZeneca completes $2B equity investment in Summit Therapeutics
4d ago
AZN
SMMT
AstraZeneca invests $2bn in Summit to accelerate bispecific and ADC cancer portfolio
PremiumCompany Announcements
AstraZeneca invests $2bn in Summit to accelerate bispecific and ADC cancer portfolio
4d ago
AZN
Summit Therapeutics enters trial collaboration with AstraZeneca, Daiichi Sankyo
PremiumThe Fly
Summit Therapeutics enters trial collaboration with AstraZeneca, Daiichi Sankyo
7d ago
AZN
SMMT
AstraZeneca, Daiichi Sankyo and Summit expand ADC–immunotherapy push with Datroway–ivonescimab trials
PremiumCompany Announcements
AstraZeneca, Daiichi Sankyo and Summit expand ADC–immunotherapy push with Datroway–ivonescimab trials
8d ago
AZN
AstraZeneca Adds Employee Scheme Shares to London Listing
PremiumCompany Announcements
AstraZeneca Adds Employee Scheme Shares to London Listing
8d ago
AZN
AstraZeneca Confirms Total Voting Rights and Share Capital Structure
PremiumCompany AnnouncementsAstraZeneca Confirms Total Voting Rights and Share Capital Structure
8d ago
AZN
AstraZeneca Secures $2 Billion Summit Therapeutics Oncology Partnership, Bolstering GI Cancer Pipeline and Supporting Buy Rating on AZN
Premium
Ratings
AstraZeneca Secures $2 Billion Summit Therapeutics Oncology Partnership, Bolstering GI Cancer Pipeline and Supporting Buy Rating on AZN
10d ago
AZN
Morning Movers: Summit Therapeutics jumps after AstraZeneca investment
Premium
The Fly
Morning Movers: Summit Therapeutics jumps after AstraZeneca investment
10d ago
MU
AIR
AstraZeneca’s Oncology Strategy and Summit Deal Reinforce Growth Outlook; Buy Rating and $178 Price Target Reiterated
PremiumRatings
AstraZeneca’s Oncology Strategy and Summit Deal Reinforce Growth Outlook; Buy Rating and $178 Price Target Reiterated
10d ago
AZN
AstraZeneca’s Summit Partnership Bolsters Oncology Strategy; Buy Rating Reiterated with Unchanged 16,500 GBp Price Target
PremiumRatings
AstraZeneca’s Summit Partnership Bolsters Oncology Strategy; Buy Rating Reiterated with Unchanged 16,500 GBp Price Target
10d ago
AZN
Summit Therapeutics price target raised to $43 from $40 at Citi
PremiumThe Fly
Summit Therapeutics price target raised to $43 from $40 at Citi
10d ago
AZN
SMMT
AstraZeneca invests $2bn in Summit Therapeutics, deepening oncology ADC-bispecific ties
PremiumCompany Announcements
AstraZeneca invests $2bn in Summit Therapeutics, deepening oncology ADC-bispecific ties
11d ago
AZN
Hutchmed says AstraZeneca submits NDA for ORPATHYS+TAGRISSO in NSCLC
PremiumThe FlyHutchmed says AstraZeneca submits NDA for ORPATHYS+TAGRISSO in NSCLC
11d ago
AZN
HCM
Closing Bell Movers: Summit Therapeutics jumps on AstraZeneca investment
Premium
The Fly
Closing Bell Movers: Summit Therapeutics jumps on AstraZeneca investment
11d ago
AIR
AZN
Summit Therapeutics up 15% after AstraZeneca makes $2B equity investment
Premium
The Fly
Summit Therapeutics up 15% after AstraZeneca makes $2B equity investment
11d ago
AZN
SMMT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >